NCT02631772View on ClinicalTrials.gov

LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

May 30, 2018

Study Completion Date

June 30, 2018

Conditions
Hepatitis C
Interventions
DRUG

Sofosbuvir/Ledipasvir x 12 weeks

DRUG

Sofosbuvir/Ledipasvir + Ribavirin x 12 weeks

Trial Locations (4)

15213

University of Pittsburgh Medical Center, Pittsburgh

20057

Medstar Georgetown University Hospital, Washington D.C.

29425

Medical University of South Carolina, Charleston

44106

University Hospitals Cleveland Medical Center, Cleveland

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT02631772 - LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients | Biotech Hunter | Biotech Hunter